Literature DB >> 20011454

NORMAL FATTY ACID CONCENTRATIONS IN YOUNG CHILDREN WITH PHENYLKETONURIA (PKU).

Stacey M Lavoie1, Cary O Harding, Melanie B Gillingham.   

Abstract

The objective of this study was to determine if children with phenylketonuria (PKU) have lower fatty acid concentrations in total erythrocyte lipid due to the phenylalanine restricted diet therapy compared to healthy control subjects. Dietary intake and fatty acid concentrations in total erythrocyte lipid were measured in twenty-one subjects (</=6 years of age) with PKU and twenty-three control children. Subjects with PKU had significantly lower protein and significantly higher polyunsaturated fat intake compared to controls. Subjects with PKU had significantly lower concentrations in total erythrocyte lipid of the sum of the omega-3,omega-6, saturated and polyunsaturated fatty acids. Concentrations of fatty acids among subjects with PKU were lower than control subjects but no subject with PKU exhibited any signs or symptoms suggestive of essential fatty acid deficiency, thereby suggesting that subjects with PKU in this cohort have normal and adequate essential fatty acid concentrations in total erythrocyte lipid.

Entities:  

Year:  2009        PMID: 20011454      PMCID: PMC2791413          DOI: 10.1097/TIN.0b013e3181c621fa

Source DB:  PubMed          Journal:  Top Clin Nutr        ISSN: 0883-5691            Impact factor:   0.508


  24 in total

1.  Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia.

Authors:  C Agostoni; S Scaglioni; M Bonvissuto; M G Bruzzese; M Giovannini; E Riva
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2001-02       Impact factor: 4.006

2.  Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio.

Authors:  Petra L L Goyens; Mary E Spilker; Peter L Zock; Martijn B Katan; Ronald P Mensink
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

3.  Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet.

Authors:  K Moseley; R Koch; A B Moser
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

4.  Plasma arachidonic acid and serum thromboxane B2 concentrations in phenylketonuric children negatively correlate with dietary compliance.

Authors:  C Agostoni; F Marangoni; E Riva; M Giovannini; C Galli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1997-03       Impact factor: 4.006

5.  Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia.

Authors:  C Agostoni; N Massetto; G Biasucci; A Rottoli; M Bonvissuto; M G Bruzzese; M Giovannini; E Riva
Journal:  J Pediatr       Date:  2000-10       Impact factor: 4.406

Review 6.  Biomarkers of fat and fatty acid intake.

Authors:  Lenore Arab
Journal:  J Nutr       Date:  2003-03       Impact factor: 4.798

7.  Nutrient intake and food consumption of adolescents and young adults with phenylketonuria.

Authors:  B Schulz; H J Bremer
Journal:  Acta Paediatr       Date:  1995-07       Impact factor: 2.299

8.  Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake.

Authors:  A P Pöge; K Bäumann; E Müller; M Leichsenring; H Schmidt; H J Bremer
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

9.  Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria.

Authors:  Skadi Beblo; Hannes Reinhardt; Hans Demmelmair; Ania C Muntau; Berthold Koletzko
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

10.  Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course.

Authors:  C Murray Skeaff; Leanne Hodson; Joanne E McKenzie
Journal:  J Nutr       Date:  2006-03       Impact factor: 4.798

View more
  8 in total

Review 1.  Antioxidant treatment strategies for hyperphenylalaninemia.

Authors:  Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H Schulpis; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-05-09       Impact factor: 3.584

2.  Maternal Weight Gain Regulates Omega-3 Fatty Acids in Male, Not Female, Neonates.

Authors:  Perrie F O'Tierney-Ginn; Melanie Gillingham; Jessica Fowler; Elizabeth Brass; Nicole E Marshall; Kent L Thornburg
Journal:  Reprod Sci       Date:  2016-07-28       Impact factor: 3.060

3.  Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria.

Authors:  Serwet Demirdas; Francjan J van Spronsen; Carla E M Hollak; J Hanneke van der Lee; Peter H Bisschop; Fred M Vaz; Nienke M Ter Horst; M Estela Rubio-Gozalbo; Annet M Bosch
Journal:  Ann Nutr Metab       Date:  2017-03-24       Impact factor: 3.374

4.  A cross-sectional study of docosahexaenoic acid status and cognitive outcomes in females of reproductive age with phenylketonuria.

Authors:  Sarah H L Yi; Julie A Kable; Marian L Evatt; Rani H Singh
Journal:  J Inherit Metab Dis       Date:  2011-02-09       Impact factor: 4.982

5.  Nutrient intake, body composition, and blood phenylalanine control in children with phenylketonuria compared to healthy controls.

Authors:  Melissa Sailer; Gabriela Elizondo; Julie Martin; Cary O Harding; Melanie B Gillingham
Journal:  Mol Genet Metab Rep       Date:  2020-05-11

6.  Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis.

Authors:  Gina A Montoya Parra; Rani H Singh; Aysun Cetinyurek-Yavuz; Mirjam Kuhn; Anita MacDonald
Journal:  Orphanet J Rare Dis       Date:  2018-06-26       Impact factor: 4.123

7.  Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.

Authors:  María L Couce; Isidro Vitoria; Luís Aldámiz-Echevarría; Ana Fernández-Marmiesse; Iria Roca; Marta Llarena; Paula Sánchez-Pintos; Rosaura Leis; Alvaro Hermida
Journal:  Orphanet J Rare Dis       Date:  2016-09-09       Impact factor: 4.123

8.  The cardiovascular phenotype of adult patients with phenylketonuria.

Authors:  Aline Azabdaftari; Markus van der Giet; Mirjam Schuchardt; Julia B Hennermann; Ursula Plöckinger; Uwe Querfeld
Journal:  Orphanet J Rare Dis       Date:  2019-09-06       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.